Equities

Hyperfine Inc

HYPR:NMQ

Hyperfine Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.8931
  • Today's Change0.052 / 6.20%
  • Shares traded67.05k
  • 1 Year change-30.77%
  • Beta0.8606
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hyperfine, Inc. is a health technology company. The Company provides a Swoop Portable Magnetic Resonance Imaging System (Swoop system), which is a portable magnetic resonance imaging (MRI) system capable of providing neuroimaging at the point of care. Its Swoop system produces images at a lower magnetic field strength than conventional MRI scanners. The Swoop system is a portable, ultra-low-field (ULF) MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. MRI is used in various clinical settings for medical diagnosis, the staging of disease, and follow-up treatment. It has designed Swoop system to address an unmet need in point-of-care medical imaging through a combination of hardware and artificial intelligence (AI)-powered software services. The Company’s system operates from a Wi-Fi-capable tablet and integrates with picture archiving and communication systems (PACS).

  • Revenue in USD (TTM)11.69m
  • Net income in USD-41.93m
  • Incorporated2021
  • Employees131.00
  • Location
    Hyperfine Inc351 New Whitfield StreetGUILFORD 06437United StatesUSA
  • Fax+1 (302) 636-5454
  • Websitehttps://hyperfine.io/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cytosorbents Corp36.69m-27.54m52.55m186.00--2.78--1.43-0.5869-0.58690.77480.34860.70194.825.97197,237.50-52.69-36.00-68.27-43.5264.0868.15-75.07-62.711.21-114.700.1896--4.7910.0613.12---9.24--
Heartbeam Inc0.00-15.11m54.50m15.00--4.35-----0.6111-0.61110.000.47620.00----0.00-200.17---258.74--------------0.00-------12.94------
Apyx Medical Corp50.45m-22.81m55.43m252.00--2.74--1.10-0.6583-0.65831.460.58460.79141.774.49200,202.40-35.94-25.24-46.73-29.9763.7066.11-45.41-46.004.94-9.210.6207--17.6125.8219.28--7.99--
Alpha Pro Tech, Ltd.60.92m4.21m56.22m124.0013.380.887410.940.9230.35960.35965.225.420.89081.688.21491,250.006.1615.216.3316.0638.1940.236.9212.9315.31--0.000.00-1.215.6027.642.935.50--
DarioHealth Corp19.04m-59.90m56.37m276.00--0.7168--2.96-2.04-2.040.6332.650.15552.343.5769,000.00-43.90-73.26-51.33-87.5927.5629.54-282.38-293.542.67--0.2673---26.4122.450.5091--52.42--
InspireMD Inc6.21m-19.92m57.34m65.00--1.27--9.24-1.08-1.080.25651.810.17172.364.3795,461.54-55.10-60.59-65.08-72.9729.1220.46-320.97-334.786.99--0.00--20.0011.50-7.71--41.57--
Medinotec Inc3.05m-566.90k58.67m29.00--28.27--19.24-0.0483-0.04830.25980.17690.67122.0616.96105,130.70-12.48---13.23--53.56---18.59--8.571.440.4323---3.91---184.47------
Envoy Medical Inc316.00k-29.91m60.96m34.00------192.90-2.60-2.600.0207-0.0899------9,294.12---------149.68---9,464.56--0.8169-266.25----33.33---87.83------
Beyond Air Inc689.00k-66.70m62.88m98.00--2.34--91.26-2.13-2.130.02190.58670.0111.441.247,030.61-112.64-70.88-148.49-88.69-115.24---10,288.68-1,530.313.26--0.382-------29.27------
Hyperfine Inc11.69m-41.93m64.31m131.00--0.8502--5.50-0.5858-0.58580.16331.050.11271.032.8089,251.91-40.40---43.95--42.39---358.59--8.26------61.90--39.54------
Monogram Technologies Inc365.00k-13.39m65.56m28.00------179.61-0.4414-0.44140.012--0.0316----13,035.71-115.81-119.26-226.52-257.400.00---3,669.37-5,045.60----0.00-------0.3964---15.97--
DIH Holding US Inc60.30m-1.77m65.68m--------1.09-0.0435-0.04351.49-0.8079----------------60.18---2.93--0.26561.50----12.15--80.41------
Pro-Dex Inc48.24m5.00m66.67m146.0014.022.1711.031.381.391.3913.448.980.97462.303.68330,438.3010.1115.4312.9418.8728.2533.1510.3714.922.16--0.27530.009.6215.4654.7232.380.8422--
Asensus Surgical Inc8.72m-78.71m70.80m207.00--5.43--8.12-0.3065-0.30650.03390.04790.12711.7913.0942,144.93-114.63-71.10-146.89-79.04-52.04-71.39-902.25-1,207.710.689--0.00--21.02-18.67-3.80---6.14--
Vivos Inc18.00k-3.20m71.58m10.00--53.35--3,976.92-0.0087-0.00870.000050.00340.0127--3.13---225.38-202.25-235.64-552.77-33.3310.79-17,805.45-11,969.07----0.00---46.58---17.19------
Data as of May 17 2024. Currency figures normalised to Hyperfine Inc's reporting currency: US Dollar USD

Institutional shareholders

15.90%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 20243.16m5.76%
10xDNA Capital Partners GmbHas of 28 Mar 20241.99m3.64%
Avidity Partners Management LPas of 31 Dec 20231.19m2.17%
BlackRock Fund Advisorsas of 31 Mar 2024689.28k1.26%
Geode Capital Management LLCas of 31 Dec 2023480.25k0.88%
Alyeska Investment Group LPas of 31 Dec 2023375.00k0.69%
Isthmus Partners LLCas of 31 Mar 2024313.35k0.57%
SSgA Funds Management, Inc.as of 31 Dec 2023175.60k0.32%
Bridgeway Capital Management LLCas of 31 Dec 2023171.60k0.31%
Newton Investment Management North America LLCas of 31 Mar 2024166.29k0.30%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.